Business Context and Reporting Period
Stereotaxis, Inc. filed this Form 8-K on October 23, 2013, to report preliminary financial results for the third quarter of fiscal year 2013 (ended September 30, 2013). The Company is a medical technology firm based in St. Louis, Missouri.
Key Financial Metrics
- Total Revenue: Approximately $10.6 million to $11.1 million.
- Revenue Breakdown: System revenue between $4.4 million and $4.6 million; recurring revenue between $6.2 million and $6.5 million.
- Operating Expenses: Between $8.2 million and $8.6 million.
- Non-Cash Expense: Approximately $50 million in mark-to-market expense related to capital transactions with convertible note holders and equity investors.
- Liquidity: Cash and cash equivalents of approximately $8.4 million as of September 30, 2013.
- Cash Burn: Estimated quarterly cash burn between $1.0 million and $2.0 million.
- Backlog: One new Niobe system order added; estimated ending capital backlog between $5.2 million and $5.6 million.
Material Changes and Operational Trends
- Utilization Decline: System utilization decreased approximately 11% compared to the prior year's third quarter and 12% compared to the second quarter of 2013.
- Profitability Impact: The filing does not provide a clear net income or loss figure due to the preliminary nature of the report and the significant $50 million non-cash mark-to-market expense.
Outlook, Risks, and Management Commentary
Management noted that the reported results are preliminary and subject to change pending the definitive announcement and the filing of the Form 10-Q, scheduled for November 2013. The significant non-cash mark-to-market expense indicates volatility in the valuation of recent capital instruments. The decline in utilization rates represents a material operational headwind.
Investor Verification Checklist
- Verify the definitive net loss figure once the Form 10-Q is filed, given the $50 million non-cash charge.
- Confirm the specific drivers behind the 11% year-over-year decline in system utilization.
- Monitor the company's cash runway given the $8.4 million cash balance and estimated quarterly burn of $1.0 million to $2.0 million.
- Review the terms of the convertible notes and equity transactions causing the mark-to-market expense.